Pre-Exposure Prophylaxis
People with HCV and opioid use disorder have low PrEP uptake, adherence
HIV PrEP uptake and adherence were low among a cohort of people with opioid use disorder who were undergoing treatment for hepatitis C virus, despite many of them meeting CDC criteria for PrEP use, according to a study.
HIV self-testing plus biofeedback counseling increases PrEP adherence among women
An intervention for PrEP users and their partners that combined oral HIV self-testing with adherence biofeedback counseling almost doubled the recent adherence to PrEP among postpartum women in South Africa compared with standard of care.
FDA approves first long-acting injectable for HIV prevention
The FDA on Monday approved ViiV Healthcare’s cabotegravir as the first long-acting injectable for HIV PrEP.
PrEParing for the next phase of COVID-19: Protective layers for immunocompromised patients
CDC says all sexually active patients should be told about HIV PrEP
The CDC on Wednesday recommended that all sexually active adults and adolescent patients be informed about HIV PrEP.
PrEP awareness, referrals low among Hispanic, Latino people
Only around a quarter of Hispanic/Latino people receiving a CDC-funded HIV test were aware of PrEP, and an even smaller proportion of those eligible for the HIV prevention medication were referred to a PrEP provider, a study found.
COVID-19 PrEP for immunosuppressed patients: The time is now
For some time now, we have been discussing COVID-19 as two epidemics. One is the tragic and unnecessary epidemic among those unwilling to be vaccinated who are pushing our fragile health care system to the limit, unnecessarily spreading the infections throughout the community, including to the most vulnerable. The other is one of breakthrough infections in those who have done what they can to protect themselves by being partially or fully vaccinated.
Nearly half of MSM taking HIV PrEP tested positive for gastrointestinal pathogens
In a small study, researchers detected gastrointestinal pathogens in 45% of men who have sex with men taking HIV PrEP, according to findings published in Open Forum Infectious Diseases.
PrEP disparities worsened in recent years, study finds
A retrospective analysis showed increasing disparities in HIV PrEP uptake between early and late adopting states between 2014 and 2018, researchers reported.
On-site PrEP access reduces HIV incidence by half in South African women
On-site access to PrEP during a clinical trial reduced HIV incidence by around 50%, according to a study of South African women published in The Lancet HIV.